P450 - LBA_ECE_1110 - Evaluation of a nutraceutical based on white mulberry leaves, fenugreek, niacin, chrome, zinc and a probiotic for reducing insulin resistance in patients with prediabetes: the NoDiab study

医学 糖尿病前期 耐受性 保健品 内科学 胰岛素抵抗 人口 2型糖尿病 糖尿病 烟酸 内分泌学 人体测量学 血脂谱 中止 胰岛素 药丸 二甲双胍 生理学 临床营养学 随机对照试验 入射(几何) 超重 聚乙二醇干扰素 升糖指数
作者
Francisco Javier Martínez-Martín,Sara Andrada-Diaz,Agnieszka Kuzior,Ana Maria Sanchez Garcia,Juan Fernández-Jiménez,Irene Hernandez-Hernandez,Facundo Marcelo Guerrero-Kesselman,Borja Santana-Ojeda,Inmaculada Molinero-Marcos,Claudia Arnas-Leon
出处
期刊:European journal of endocrinology [Oxford University Press]
卷期号:195 (Supplement_1): lvag096.569-
标识
DOI:10.1093/ejendo/lvag096.569
摘要

Introduction and Objectives In the adult Spanish population the prevalence of prediabetes has been estimated at 15%, with an annual diabetes incidence of 1.16% (approximately 386 000 individuals). While metformin, glitazones, GLP-1RAs and SGLT2is may reduce this risk, none is currently approved for this indication. Acarbose, an α-glucosidase inhibitor, reduces the risk of progression to T2DM (STOP-NIDDM trial). White mulberry (Morus Alba) leaves contain 1-deoxynojirimycin, a potent α-glucosidase inhibitor. A nutraceutical based on a standardized white mulberry leaf extract, also containing fenugreek, inulin, Lactiplantibacillus plantarum A14, chromium, zinc and niacin has been developed for the treatment of prediabetes. We conducted an open-label trial (NoDiab) to evaluate the tolerability and efficacy of this nutraceutical, using the HOMA2-IR index (a validated predictor of T2DM development) as the primary outcome. Methods Adult subjects with prediabetes were recruited, excluding those with morbid obesity, serious concomitant diseases, alcoholism, substance abuse, and current or planned pregnancy. After informed consent, baseline anthropometry and laboratory tests, they were instructed to take one pill of the nutraceutical daily before lunch with a glass of water. Follow- up visits are scheduled at 3-4 and 6-7 months. In addition to changes in the HOMA2-IR, secondary endpoints were HOMA2-β, 10-year cardiovascular risk (SCORE2), lipid profile, systolic BP, BMI, fasting glucose and insulin, HbA1c, albuminuria, liver fibrosis risk (FIB-4 index) and tolerability (questionnaire). Results In 113 subjects (71 women, age 56.4 ± 6.7 years), HOMA2-IR decreased from 1.659 ± 0.721 to 1.269 ± 0.581 (P < .001) while HOMA2-β remained unchanged; SCORE2 decreased from to 4.23 ± 1.98 to 3.58 ± 1.76% (P < .001); non-HDLc from 161.5 ± 31.2 to 145.1 ± 20.9 mg/dL (P < .001); systolic BP from 138.8 ± 13.6 to 133.1 ± 11.2 mmHg (P < .001); fasting glucose from 107.5 ± 10.8 to 98.5 ± 8.9 mg/dL (P < .001); fasting insulin from 12.6 ± 6.1 to 9.7 ± 4.4 μU/ml (P < .001); HbA1c from 6.06 ± 0.24 to 5.83 ± 0.18% (P < .001); albuminuria from 28.4 ± 15.2 to 21.5 ± 14.3 mg/g Cr (P = .035); C-reactive protein from 3.66 ± 1.97 to 2.89 ± 1.27 mg/dL (P < .001); FIB-4 index from 1.42 ± 0.25 to 1.22 ± 0.24 (P = .003). Weight reduction was non-significant. No serious tolerability issues were reported, and no patient withdrew from the study due to adverse effects. Conclusions In the open-label NoDiab study, this nutraceutical produced a significant reduction in insulin resistance (−22.5%), along with improvements in the cardiovascular risk profile of prediabetic subjects (15.4% reduction in SCORE2, 9.9% in non-HDL cholesterol and 5.7 mmHg in systolic BP), with excellent tolerability. Prediabetes is primarily managed through lifestyle modifications, but their effectiveness is limited and no pharmacological options are currently approved; this nutraceutical may help fill this therapeutic gap.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
福yyy发布了新的文献求助10
1秒前
jianghuren发布了新的文献求助10
2秒前
Zz发布了新的文献求助10
3秒前
zxzx发布了新的文献求助10
5秒前
horse完成签到,获得积分10
5秒前
TOT完成签到,获得积分10
6秒前
天天快乐的应助被绪绪采纳,获得10
6秒前
7秒前
9秒前
9秒前
lila完成签到,获得积分10
12秒前
12秒前
12秒前
12秒前
浮生发布了新的文献求助20
13秒前
trx发布了新的文献求助10
13秒前
csy完成签到,获得积分10
14秒前
科目三的应助被孟庆亮采纳,获得10
14秒前
14秒前
14秒前
子夜歌发布了新的文献求助20
16秒前
hoyden完成签到,获得积分10
17秒前
up0818完成签到 ,获得积分10
17秒前
LQY完成签到 ,获得积分10
18秒前
shao发布了新的文献求助10
18秒前
邵蹦蹦发布了新的文献求助10
18秒前
Attendre发布了新的文献求助10
18秒前
19秒前
20秒前
20秒前
兜里有糖完成签到,获得积分10
21秒前
21秒前
21秒前
Seven发布了新的文献求助10
21秒前
24秒前
Maestro_S的应助被科研通管家采纳,获得10
24秒前
niu完成签到 ,获得积分10
24秒前
汉堡包的应助被科研通管家采纳,获得10
24秒前
SciGPT的应助被科研通管家采纳,获得10
24秒前
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8186750
求助须知:如何正确求助?哪些是违规求助? 9575027
关于积分的说明 21839240
捐赠科研通 7784331
什么是DOI,文献DOI怎么找? 3434808
关于科研通互助平台的介绍 2559206
邀请新用户注册赠送积分活动 2481611